Publications & Presentations: Our Medical & Scientific Expertise in Action

Since 2007, we have worked across client organizations to design and execute scientifically rigorous studies that contribute to the body of relevant literature. Review our library of published papers and presentations that illustrate our interpretation of research, our thought leadership, and our analytical prowess.

At KJT, we are at the forefront of innovation and medical research. Blending academic rigor with insights to drive impactful advancements in healthcare, we are committed to providing robust, evidence-based research, and well-informed recommendations.

Our team of experts brings extensive knowledge of disease states and the complexities involved in the medical field to organizations committed to making active strides in healthcare innovation and medical science.

See firsthand the value we bring to the healthcare community and explore our library of publications showcasing the rigorous research and evidence we’ve contributed.

Our Experience

Published Manuscripts

Abstracts

Posters

Oral (Podium) Presentations

Disease/Therapeutic Areas Supported

Featured
November 2022
Ophthalmology, Published Manuscript, KJT Author

Economic Impact Analysis of Custom Pak® on Cataract and Vitreoretinal Surgery in the United States

Featured
March 2015
Neurology, Published Manuscript, KJT Author

Concussions are associated with decreased batting performance among Major League Baseball Players

Wasserman EB, Abar B, Shah MN, Wasserman D, Bazarian JJ. Concussions are associated with decreased batting performance among Major League Baseball players. Am J Sports Med. 2015 May;43(5):1127-33. doi: 10.1177/0363546515576130. Epub 2015 Mar 17. PMID: 25784627.

Although concussed players may be asymptomatic upon return to play, the residual effects of concussion on the skills required for batting may still be present.

Filters

August 2024
Cardiometabolic Disorders, Published Manuscript, KJT Medical Writer

Diagnostic and therapeutic challenges for PCPs regarding heart failure with preserved ejection fraction and obesity: results of an online internet-based survey

Campos, C., Magwire, M., Butler, J. et al. Diagnostic and therapeutic challenges for PCPs regarding heart failure with preserved ejection fraction and obesity: results of an online internet-based survey. BMC Prim. Care 25, 288 (2024). https://doi.org/10.1186/s12875-024-02549-4

Many HFpEF patients waited nearly a year to consult a PCP about their symptoms, with limited diagnoses and management by PCPs, highlighting a need for obesity management training.

June 2024
Cardiometabolic Disorders, Published Manuscript, KJT Medical Writer

Perspectives in Managing Kidney Disease and Atherosclerotic Cardiovascular Disease

Tarlan Namvar, Matthew A. Cavender, Eden Miller, Sherif Mehanna, Reese Ochsner, Dominic S. Raj; Perspectives in Managing Kidney Disease and Atherosclerotic Cardiovascular Disease. Cardiorenal Med 14 May 2024; 14 (1): 426–436. https://doi.org/10.1159/000539804

A survey of patients with CKD and ASCVD revealed differing levels of understanding between patients and healthcare providers regarding their conditions and the importance of nephrologists in managing these patients’ risks.

June 2024
Cardiometabolic Disorders, Published Manuscript, KJT Medical Writer

Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patients

Butler, J., Shah, S. J., Magwire, M., Campos, C., Usman, M. S., Hoovler, A., Sabharwal, A., & Borlaug, B. A. (2024). Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patients. Global Cardiology, 2(2). https://doi.org/10.4081/cardio.2024.38

While nearly half of HFpEF patients received timely diagnoses, most waited significantly longer and were primarily managed by cardiologists, who favored lifestyle changes and were largely untrained in obesity management.

March 2024
Metabolic & Endocrine Disorders, Published Manuscript, KJT Medical Writer

Greater persistence and adherence to basal insulin therapy is associated with lower healthcare utilization and medical costs in patients with type 2 diabetes: a retrospective database analysis

Aroda VR, Nielsen N, Mangla KK, et alGreater persistence and adherence to basal insulin therapy is associated with lower healthcare utilization and medical costs in patients with type 2 diabetes: a retrospective database analysisBMJ Open Diabetes Research and Care 2024;12:e003825. doi: 10.1136/bmjdrc-2023-003825

Among 64,953 patients, those demonstrating persistence and adherence to treatment had lower hospitalization rates and direct medical costs, with prior use of both oral and injectable antidiabetic medications predicting better outcomes.

February 2024
Metabolic Disorders, Published Manuscript, KJT Medical Writer

Semaglutide 2.4 mg clinical outcomes in patients with obesity or overweight in a real‐world setting: a 6‐month retrospective study in the United States (SCOPE).

Ruseva A, Michalak W, Zhao Z, Fabricatore A, Hartaigh BÓ, Umashanker D. Semaglutide 2.4 mg clinical outcomes in patients with obesity or overweight in a real-world setting: a 6-month retrospective study in the United States (SCOPE). Obes Sci Pract. 2024;e737. https://doi.org/10.1002/osp4.737

A real-world study showed that semaglutide 2.4 mg effectively reduced body weight and improved cardiometabolic parameters over six months in patients with overweight or obesity, aligning with previous clinical trial outcomes.

February 2024
Metabolic & Endocrine Disorders, Published Manuscript, KJT Medical Writer

Evaluating Patient and Provider Preferences for a Once-Weekly Basal Insulin in Adults with Type 2 Diabetes

Pages: 1234567891011121314151617